A multicentre national audit of the recording of patients weight: Implications for the prescription of gentamicin and therapeutic-dose low molecular weight heparin  by Willson, Jamie et al.
Abstracts / International Journal of Surgery 10 (2012) 641e645 643
ABSTRACTSto determine the functional health status of patients who had undergone
the procedure.
Methods: The study included 189 patients undergoing the procedure
between 1983 and 2010, 78 females and 111males (mean age 8.39 years). A
child health questionnaire CHQ-PF50 was ﬁlled in by the parents. The
scores were transformed into a 0-100 scale and divided into physical and
psychosocial functioning. Data was collected by reviewing hospital records
and analysis carried out with the JMP statistical software.
Results: The group of respondents was 25 out of 100, out of which 15
identiﬁed patients. 14 patients from the whole cohort were deceased. The
highest score of the physical (PhS) functioning: 76.27, the psychosocial
(PsS) functioning: 62.44. The lowest score for the PhSwas 16.03 and for PsS
11.43. Mean score for PhS was 40.05 and for PsS 47.34. The median years
after the Fontan operation: 3.6 years and the median age: 4.4 years. The
results show the mean PhS being below the average for the general U.S
population while just below the average in PsS.
Conclusions: The functional health outcome of patients after the Fontan
operation is below the average in a physical aspect and just below the
average psychosocially.
Considering it is a complex congenital heart disease this might bewhat can
be expected from these individuals.
Keywords: Cardiac surgery, Single ventricle, Fontan procedure, Functional
health outcome
ENDOSCOPIC PALLIATION OF MALIGNANT BILIARY OBSTRUCTION. ARE
METAL STENTS WORTH THE COST?
Hayley Heffernan, Irina Baimatova, Gemma Gossedge, Mike Zeiderman.
Southport District General Hospital, United Kingdom
Introduction: This study was designed to determine whether the use of
plastic stents should be abandoned on the basis of effectiveness and cost.
Method: The records of all patients with malignant biliary obstruction,
who underwent ERBD at Southport Hospital between 2005 and 2010, were
reviewed. Patients with nonmalignant biliary obstruction, obstruction due
to other primary malignancies and those lost to follow up were excluded.
The incidence of complications, patency rates, readmissions and time
spent in hospital were recorded. Cost was calculated from NHS tariff of
ERCP + plastic stent at £835 and metal stent at £1496.
Results: 49 patients were included. M:F 27:22. Median age 77 years (range
59e96). 46 patients had plastic stents and 3 had metal stents inserted.
Diagnoses e pancreatic carcinoma (36), cholangiocarcinoma (8), ampul-
lary carcinoma (5). Median bilirubin at time of ﬁrst ERCP e 301 mmol/L
(range 62e759).
There were no immediate procedure-related complications.
Eight patients (17%) represented with blocked plastic stents at a median
time of 80 days (range 3e280). Of these, 6 patients had a plastic and one
had a metal stent re-inserted.
If primary treatment had been with metal stents then the cost would have
been £73,304. Allowing for readmissions and stent changes, total cost for
the plastic stent group was £47,301, a saving of £26,003.
Conclusion: Plastic stents provide long-term palliation of ERBD for the
majority of patients and should be accepted as ﬁrst line treatment. The cost
of primary treatment with metal stents cannot be justiﬁed.
QUALITY OF LIFE AFTER THERAPEUTIC MAMMOPLASTY
Dr. Iram Haq, K.L. Kirkpatrick, G. Mitchell, A.P. Tansley. Mersey Foundation
School (FY1), United Kingdom
Aims: Therapeutic mammaplasty (TM) is increasingly used to treat breast
tumours where breast size allows; no data exists for subsequent Quality of
Life (QoL). This pilot study assessed QoL to provide evidence for TM as an
appropriate technique.
Methods: A QoL questionnaire was employed incorporating six validated
tools including the European Organisation for Research and Treatment of
Cancer QoL questionnaire for breast cancer, on patients undergoing TM
from 2006 to 2010. Cosmesis was judged by medical and non-medical
personnel.
Results: 46 patients (average BMI 30 kg/m2 (range 23e40)), underwent
TM, 96% for malignancy. Preoperative estimated breast volume was
226d2592 cm3 (mean 1061cm3), predicted percentage resection 0.8e35%(mean 10%); ultimate average resection was 258 g (36e1067 g). Compli-
cations predominantly fat necrosis, occurred in 24%, ﬁve patients required
completion mastectomy, 96% received adjuvant radiotherapy.
QoL scores (n¼36) were excellent with a mean of 73% [95% CI 68e78],
psychosexual function subset scored highest (83%). Mean cosmesis score
was 67% [95% CI 61e73], comparable with previously reported data. QoL
increased by 14% from 6 months to 3 years despite 10% cosmesis decline.
Conclusion: This study suggests good sustained QoL after TM, supporting
its use in selected patients. Mastectomy may not be avoided and coun-
seling should reﬂect this.
LONG TERM OUTCOMES OF CYCLODIODE THERAPY FOR RAISED
INTRAOCULAR PRESSURE AT A UK TEACHING HOSPITAL
Ivailo Zhekov. University of Cambridge Clinical School, United Kingdom
Aim: The main aims of this study were to investigate the dose-response
relation of the cyclodiode treatment and to evaluate possible predictive
factors that would help establish optimum parameters. The outcomes of
the procedure were evaluated both post-operatively and through long-
term follow-up.
Methods: A retrospective review of 87 patients who underwent trans-
scleral diode laser cyclophotocoagulation procedure from 2004 through
2011.
Results: Mean intraocular pressure (IOP) decreased signiﬁcantly from
39.54 mmHg (SE 1.26) before cyclodiode therapy to 17.83 mmHg (SE 1.51)
post-treatment, a reduction of 45.09% (p< 0.0001). This wasmeasured at 6
weeks andmaintained for 3 years. Pressure reduction of>30% of initial IOP
was achieved in 72.34% of the patients. This was greater (80.3%) in the
group receiving extensive treatment (90J). In addition, a signiﬁcant
proportion of the patients that underwent cyclodiode therapy (63.45%)
decreased their number of IOP lowering medications postoperatively from
2.56 to 1.59. Hypotony occurred in 5.31% of patients, predominantly in
patients receiving extensive treatment (90e120J), however none of the
patients developed further complications or required enucleation. Neo-
vascular glaucoma was a signiﬁcant risk factor. Visual acuity (VA)
remained unchanged or improved for the majority of the patients under-
going a cyclodiode procedure (83.55%) and was maintained long-term.
Conclusion: Cyclodiode therapy is a highly effective method for achieving
reduction of Intraocular Pressure and long-term maintenance of Visual
Acuity in patients with glaucoma.
A MULTICENTRE NATIONAL AUDIT OF THE RECORDING OF PATIENTS
WEIGHT: IMPLICATIONS FOR THE PRESCRIPTION OF GENTAMICIN
AND THERAPEUTIC-DOSE LOW MOLECULAR WEIGHT HEPARIN
Dr. Jamie Willson, Dr. Sebastian Thomas, Mr. Jonathan Horsnell, Dr.
Soumen Sen, Dr. Strachan Mackenzie, Dr. Arti Patel, Dr. William Ratliff,
Dr. Sabrina Black, Dr. Sarasvati Chauhan, Dr. Alice Armitage, G.P. Tarr, Dr.
Kathryn Garnham, Dr. Alistair Robb. Imperial College School of Medicine
(FY2), United Kingdom
Objectives: Identify the percentage of patients being weighed in hospital
and the proportion of these prescribed gentamicin or therapeutic dose low
molecular weight heparin (t-LMWH).
Design: Retrospective review of drug charts and bedside notes of all
secondary care hospital inpatients across 5 wards; 2medical, 2 surgery and
1 peadiatrics chosen at random in 11 hospitals in England and Wales.
Results: A total of 48.5% (515/1061) of hospital inpatients had their weight
recorded (paediatric wards 98% (77/78), adult wards 45.8% (438/983)). The
range of recording between hospitals was 23.0% and 93.3%. In total 113
patients audited were receiving either Gentamicin of t-LMWH; 65.2% (73/
113) of which had a recorded weight. Of those receiving t-LMWH: 74.2%
(49/66) were weighed vs 56.6% (30/53) of those receiving Gentamicin.
There was large variation between hospitals in recording weight of
patients receiving Gentamicin or t-LMWH, 25.0%e100% (1/4e6/6).
Conclusions: Over half of the inpatients are not being weighed in hospital,
falling short of NICE and DoH guideline to weigh all hospital patients. This
failure leaves patients at risk of undetected malnutrition, which increases
the risk of mortality, post-operative complications and lengthened
hospitals stays. Furthermore, patient on drugs requiring a weight speciﬁc
dose, are at greater risk of severe side effects or subtherapeutic drug
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ABSTRACTSdosing. Potential initiatives to improve the proportion of patients weighed
include, better staff education, a strategic approach to recording patients
notes and electronic prescribing.
THE IMPACT OF SURGICAL APPROACH ON THE ANATOMY OF ANTERIOR
CRUCIATE LIGAMENT RECONSTRUCTION
K. Aboelmagd, M. El-Husseiny, F.S. Haddad. UCL Medical School, United
Kingdom
The Transtibial (TT) approach to anterior cruciate ligament (ACL) recon-
struction has produced excellent clinical results, however some patients
still experience persistent rotational tibial instability and graft failure.
Non-anatomic femoral tunnel positioning has been associated with
unsuccessful ACL reconstructions. This study compares the position and
length of femoral tunnels produced from TT and Transportal (TP)
approaches to ACL reconstruction.
Post-operative radiographs were obtained from 122 patients who under-
went single-bundle ACL reconstruction. Two groups were assigned; Group
1 contained 80 patients who underwent TT reconstruction, Group 2 con-
tained 42 patients who underwent TP reconstruction. Femoral tunnel
angle, length and positionweremeasured in the coronal and sagittal plane.
Data analysis used the Mann Whitney U test, with P < 0.05 deﬁned as
signiﬁcant. Inter and intra observer reliability was determined using the
intraclass correlation coefﬁcient.
TP femoral tunnels were signiﬁcantly shorter, p < 0.0001, (TP median 38.1
mm, TT median 48.44 mm), and more oblique in the coronal plane, p <
0.0001, (TP median 44.3, TT median 58.6). TP femoral tunnels were posi-
tioned further around the clock face, p< 0.0001, (TPmedian 47.1, TTmedian
30.2), and signiﬁcantlymoreposteriorlyalongBlumensaat's line, p< 0.0001,
(TP median 69.79%, TT median 61.64%). Sagittal plane TP tunnels were
signiﬁcantly more oblique, p < 0.0001, (TP median 60.8 , TT median 79).
This study has shown that the TP approach to ACL reconstruction produces
shorter and more oblique femoral tunnels positioned more posteriorly
along the femoral notch compared to TT femoral tunnels.
SURVEY OF ANTIBIOTIC PROPHYLAXIS FOR INFECTIVE ENDOCARDITIS
(IE) IN UK DENTAL PRACTICES 3-YRS FOLLOWING NICE: WHAT
DENTISTS DO AND WHAT PATIENTS WANT
Matilda Powell-Bowns. Dundee Medical School, United Kingdom
Background: NICE guidelines published in 2008 recommend no prophy-
laxis for any cardiac patient undergoing dental or non-dental manipula-
tions except for procedures at an infected non-dental site. This is in
contrary to recommendations from other international bodies.
Objectives:
 To evaluate compliance in UK dental practices to NICE
guidelines.
 To obtain ‘at-risk’ patients’ opinion regarding the use of IE
prophylaxis.
Methods: 200 dental practices were randomly selected from a cohort of
5253 across eighteen UK counties. The practices received a questionnaire
regarding their IE prophylaxis policy and reviewed their current practise
regarding this matter.
50 pre- and post-operative patients considered to be “at-risk” by NICE
underwent a telephone survey. The survey discussed current guidelines
regarding IE prophylaxis and questioned patients regarding their
preference.
Results: 46.5% dental practices responded, of which 96% reported
following NICE guidelines. 46% of the respondents still prescribed
prophylactic IE antibiotics. 22% of respondents correctly identiﬁed cardiac
patients “at-risk”.
100% of patients contacted completed the study. 52% patients felt they
warranted IE prophylaxis. 74% were unaware that NICE do not recommend
prophylaxis irrespective of risk. 96% of patients would prefer to have
prophylaxis.
Conclusion: The study suggests 36 months following publication of NICE
guidelines; dentists remain unsure regarding IE prophylaxis. Consideringthat the majority of informed “at-risk” patients want to receive prophy-
laxis, there is possibly now a need to review the NICE guidelines.
THE IMPACT OF A SINGLE SURGICAL INTERVENTION FOR PATIENTS
WITH CLEFT LIP AND PALATE LIVING IN EASTERN ETHIOPIA
Matthew Fell. Severn Foundation School (FY1), United Kingdom
Aims: Humanitarian organisations commonly provide reconstructive treat-
ment for patients with cleft lip and/or palate (CLP) in developing countries
where care is otherwise unavailable. This study aimed to assess whether
a single surgical interventionwas sufﬁcient to produce an observable change
in the life of a patient with CLP living in rural Hararghe in eastern Ethiopia.
Methods: 356 patients with a cleft lip and/or palate, who received surgical
treatment at least 6 months previously, were interviewed and examined in
21 rural health centres in Ethiopia.
Results: Cleft patients and their families expressed unhappiness before
treatment, mainly because the society reacted negatively towards the
deformity, isolating the patient from community activities. After the oper-
ation, the vastmajority (98.5%) experienced apositive improvement in their
lives. The percentage of school-aged children participating in education
almost doubled (from 44% to 78%), some older patients were able tomarry,
but employment was unaffected. The type of cleft was the biggest factor in
predicting outcome, with unilateral cleft lip patients having the best result.
Bilateral cleft lip patients tended tohaveagoodoutcomebut thedehiscence
rate (8%) was higher than unilateral cleft lip (0.3%). Most patients were
satisﬁed with the treatment and outcome, but 80% of patients with an
unoperated cleft of the palate wanted further treatment.
Conclusions: This unique study has given an insight into the effectiveness
of surgical treatment for cleft lip/palate patients in a rural setting in
Ethiopia.
EVALUATION OF CT UROGRAPHY AS A SECOND-LINE INVESTIGATION IN
PATIENTS PRESENTING WITH VISIBLE HAEMATURIA IN THE HIGHLAND
REGION
Ola Blach. University of Aberdeen Medical School, United Kingdom
Background: Visible haematuria is a cardinal symptom of urinary tract
malignancy, and is commonly investigated initially with cystoscopy and
ultrasonography. CT urography replaced IV urography as the second-line
investigation in the Highlands in 2005 but its ability to detect signiﬁcant
urological pathology, not otherwise picked up by ultrasound and cystos-
copy, has never been assessed.
Design & aim: A prospective observational study comparing the diag-
nostic yield of CT urography with ﬁrst-line ultrasonography and
cystoscopy.
Results: The overall sensitivity of CT urography in detection of urological
pathologywas 94.0% vs. 61.2% of ultrasonography. Bothwere highly speciﬁc:
97.5% and 96.9%, respectively. Despite the good agreement between the two
tests (k¼0.6120.059, p< 0.001), detectability of pathologywas signiﬁcantly
higher on CT urography (McNemar: p < 0.001), with 9.3% more ‘abnormal’
cases diagnosed, including1 renal carcinoma, 2 benign renalmasses, and62%
more calculi. Urothelial malignancy and hydronephrosis were equally well
detected by both investigations. 225 ‘incidental’ lesions were identiﬁed in
137/227 patients following CT urography.
Conclusion: The management of patients with visible haematuria was not
changed signiﬁcantly by the use of CT urography. Therefore, ultrasonography
andcystoscopy should continue tobe used as theﬁrst-line tests for identifying
the source of bleeding. CT urography should be reserved as a second-line
investigation for older patients, for those with additional risk factors, and for
further evaluation of abnormalities detected onultrasound or cystoscopy. One
debatable beneﬁt of CT urography lies in its detection of incidental asymp-
tomatic pathology at the expense of additional radiation dose and higher cost.
AN OBSERVATIONAL STUDY OF TRANSFUSION MANAGEMENT IN
A CARDIAC SURGICAL UNIT IN TRINIDAD
Oliver Harrison. Severn Foundation School, United Kingdom
Cardiac surgery patients are amongst the biggest consumers of blood trans-
fusions of all surgical patients. Cell salvage devices (cell savers) have helped
reduce this requirement and the risks of transfusion (including infection
